IDIBELL (Institut d'investigació biomédica de Bellvitge)http://www.idibell.cat/en-enNoticies d'IDIBELLIDIBELLEl calendario solidario Helios recauda fondos para la investigación del cáncer infantil en el IDIBELL ]]>http://www.idibell.cat/modul/news/ca/1038/el-calendario-solidario-helios-recauda-fondos-para-la-investigacion-del-cancer-infantil-en-el-idibell2017-12-11Se presentan los Bombones Carla: una iniciativa solidaria para promover la investigación del síndrome de Rett ]]>http://www.idibell.cat/modul/news/ca/1037/se-presentan-los-bombones-carla-una-iniciativa-solidaria-para-promover-la-investigacion-del-sindrome-de-rett2017-11-29Scientists identify the segmentation and consolidation mechanism of long-term memories ]]>http://www.idibell.cat/modul/news/ca/1036/scientists-identify-the-segmentation-and-consolidation-mechanism-of-long-term-memories2017-11-27El III Premio Martí Vía para la investigación oncológica recae al Programa ProCURE ]]>http://www.idibell.cat/modul/news/ca/1035/el-iii-premio-marti-via-para-la-investigacion-oncologica-recae-al-programa-procure2017-11-27International collaboration at the ''Amino acid transport defects'' symposium ]]>http://www.idibell.cat/modul/news/ca/1034/international-collaboration-at-the-amino-acid-transport-defects-symposium2017-11-28The isoforms of the HP1 protein differentially regulate the organization and structure of heterochromatin ]]>http://www.idibell.cat/modul/news/ca/1032/the-isoforms-of-the-hp1-protein-differentially-regulate-the-organization-and-structure-of-heterochromatin2017-11-20Each year in Catalonia, roughly 1,000 women die of breast cancer and 275 of ovarian cancer ]]>http://www.idibell.cat/modul/news/ca/1033/each-year-in-catalonia-roughly-1000-women-die-of-breast-cancer-and-275-of-ovarian-cancer2017-11-27''Best Ideas 2017'' award to Manel Esteller ]]>http://www.idibell.cat/modul/news/ca/1031/best-ideas-2017-award-to-manel-esteller2017-11-17Ramon Salazar receives funding for a research project on colon cancer

The Spanish Association Against Cancer (AECC) and the Carlos III Health Institute (ISCII) have decided to financially contribute to the 'Horizon 2020 TRASCAN' program of the European Union to fund five Spanish projects

]]>
http://www.idibell.cat/modul/news/ca/1029/ramon-salazar-receives-funding-for-a-research-project-on-colon-cancer2017-11-15
El IDIBELL y el Foro Empresarial del Llobregat dedican a la esclerosis múltiple su 2ª Noche Solidaria con la investigación biomédica ]]>http://www.idibell.cat/modul/news/ca/1030/el-idibell-y-el-foro-empresarial-del-llobregat-dedican-a-la-esclerosis-multiple-su-2-noche-solidaria-con-la-investigacion-biomedica2017-11-14The ‘Viladecans Against Cancer’ Association Coordinator raises 16.186 euros for stomach cancer research in IDIBELL ]]>http://www.idibell.cat/modul/news/ca/1027/the-viladecans-against-cancer-association-coordinator-raises-16186-euros-for-stomach-cancer-research-in-idibell2017-11-13Éxito del No Limits Barcelona, la gincana urbana de la conducción ecológica y sin barreras ]]>http://www.idibell.cat/modul/news/ca/1026/exito-del-no-limits-barcelona-la-gincana-urbana-de-la-conduccion-ecologica-y-sin-barreras2017-11-06La Marató 2016 gives the grants for research projects on ictus and traumatic spinal cord and brain injuries ]]>http://www.idibell.cat/modul/news/ca/1025/la-marato-2016-gives-the-grants-for-research-projects-on-ictus-and-traumatic-spinal-cord-and-brain-injuries2017-11-03Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy ]]>http://www.idibell.cat/modul/news/ca/1024/researchers-prove-the-effectiveness-of-a-new-drug-to-prevent-the-onset-and-the-pain-of-chemotherapy-induced-neuropathy2017-10-23Researchers identify neural mechanisms that strengthen or weaken memories during sleep ]]>http://www.idibell.cat/modul/news/ca/1023/researchers-identify-neural-mechanisms-that-strengthen-or-weaken-memories-during-sleep2017-10-11A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer ]]>http://www.idibell.cat/modul/news/ca/1022/a-new-genetic-marker-accounts-for-up-to-14-of-cases-of-hereditary-colon-cancer2017-10-09IDIBELL scientists identify a key regulator of the acquisition of immune tolerance to tumor cells in cancer patients ]]>http://www.idibell.cat/modul/news/ca/1021/idibell-scientists-identify-a-key-regulator-of-the-acquisition-of-immune-tolerance-to-tumor-cells-in-cancer-patients2017-09-28El Campus de Bellvitge acoge la exposición ‘María Sklodowska-Curie, una polaca en París’ ]]>http://www.idibell.cat/modul/news/ca/1020/el-campus-de-bellvitge-acoge-la-exposicion-maria-sklodowska-curie-una-polaca-en-paris2017-09-27Success of the “H2020 Opportunities” informative session ]]>http://www.idibell.cat/modul/news/ca/1018/success-of-the-h2020-opportunities-informative-session2017-09-22Communiqué from the universities and research centres of Catalonia ]]>http://www.idibell.cat/modul/news/ca/1019/communique-from-the-universities-and-research-centres-of-catalonia2017-09-22A group of lymphangioleiomyomatosis (LAM) patients attend a talk on the disease and advances

David J. Kwiatkowski, a professor of medicine at Harvard University and an oncologist specializing in thoracic oncology at Dana-Farber Cancer Institute in Boston, was responsible for explaining the advances in genetics and clinical trials being conducted to combat the disease

]]>
http://www.idibell.cat/modul/news/ca/1016/a-group-of-lymphangioleiomyomatosis-lam-patients-attend-a-talk-on-the-disease-and-advances2017-09-13
New injectable antiretroviral treatment proved to be as effective as standard oral therapy ]]>http://www.idibell.cat/modul/news/ca/1015/new-injectable-antiretroviral-treatment-proved-to-be-as-effective-as-standard-oral-therapy2017-07-31El Grupo CataLands Solidaris da 10.000 euros al Programa ProCURE ]]>http://www.idibell.cat/modul/news/ca/1013/el-grupo-catalands-solidaris-da-10000-euros-al-programa-procure2017-07-31IDIBELL will foster three INPhINIT young researchers ]]>http://www.idibell.cat/modul/news/ca/1014/idibell-will-foster-three-inphinit-young-researchers2017-08-02Welcome Ducky, a social company committed to biomedical research ]]>http://www.idibell.cat/modul/news/ca/1012/welcome-ducky-a-social-company-committed-to-biomedical-research2017-07-25IDIBELL joins the Barcelona Bioinformatics Association ]]>http://www.idibell.cat/modul/news/ca/1011/idibell-joins-the-barcelona-bioinformatics-association2017-07-18Dr. Manel Esteller receives the Falcó Carlemany Award ]]>http://www.idibell.cat/modul/news/ca/1010/dr-manel-esteller-receives-the-falco-carlemany-award2017-07-14Nova eina d’anàlisi per a predir la resposta al tractament preoperatori en càncer de recte

Predir quins pacients no respondran al tractament pot ajudar a evitar-los efectes secundaris innecessaris i permetrà oferir-los alternatives més beneficioses, com poden ser la cirurgia programada amb major antel·lació o la participació en estudis clínics

]]>
http://www.idibell.cat/modul/news/ca/1009/nova-eina-danalisi-per-a-predir-la-resposta-al-tractament-preoperatori-en-cancer-de-recte2017-07-10
New epigenomic strategies in the clinical management of cancer of unknown primary ]]>http://www.idibell.cat/modul/news/ca/1008/new-epigenomic-strategies-in-the-clinical-management-of-cancer-of-unknown-primary2017-07-07A personalized treatment with metabolic therapy improves the motor and communication skills of a patient with atypical Rett syndrome ]]>http://www.idibell.cat/modul/news/ca/1007/a-personalized-treatment-with-metabolic-therapy-improves-the-motor-and-communication-skills-of-a-patient-with-atypical-rett-syndrome2017-07-05A new ribosomal biogenesis regulation point to treat cancer and 5q- syndrome ]]>http://www.idibell.cat/modul/news/ca/1005/a-new-ribosomal-biogenesis-regulation-point-to-treat-cancer-and-5q-syndrome2017-06-28Orgull en ciència: L’IDIBELL s’adhereix a la celebració del Dia per l’Alliberament LGTB+ ]]>http://www.idibell.cat/modul/news/ca/1004/orgull-en-ciencia-lidibell-sadhereix-a-la-celebracio-del-dia-per-lalliberament-lgtb-2017-07-04Dr. Xavier Matias-Guiu receives an ICS award for his research career ]]>http://www.idibell.cat/modul/news/ca/1006/dr-xavier-matias-guiu-receives-an-ics-award-for-his-research-career2017-06-29Facial paralysis image processing software is awarded a grant by the Academy of Medical Sciences ]]>http://www.idibell.cat/modul/news/ca/1003/facial-paralysis-image-processing-software-is-awarded-a-grant-by-the-academy-of-medical-sciences2017-06-16The complete epigenomes of the most frequent tumors, unveiled ]]>http://www.idibell.cat/modul/news/ca/1001/the-complete-epigenomes-of-the-most-frequent-tumors-unveiled2017-06-06IDIBELL leads a new European Innovative Training Network

 The four-year project will finance 15 early stage researchers to explain the relationship between cancer, metabolism and the immune system

]]>
http://www.idibell.cat/modul/news/ca/1000/idibell-leads-a-new-european-innovative-training-network2017-05-30
Scientists identify new predisposing genes and microRNAS involved in hereditary cancer

Dr. Gabriel Capellá presents the hereditary cáncer-related projects of IDIBELL at the XI AECC Symposium 

]]>
http://www.idibell.cat/modul/news/ca/999/scientists-identify-new-predisposing-genes-and-micrornas-involved-in-hereditary-cancer2017-05-18
IDIBELL and CMRB launch a new Catalan Regenerative Medicine Program

The Center of Regenerative Medicine in Barcelona (CMR[B]) - currently located within the Barcelona Biomedical Research Park (PRBB) - and the Bellvitge Biomedical Research Institute (IDIBELL) have joined efforts to create the new Regenerative Medicine Program of Catalonia (P-CMR[C]).

]]>
http://www.idibell.cat/modul/news/ca/998/idibell-and-cmrb-launch-a-new-catalan-regenerative-medicine-program2017-05-08
Starvation causes atypical cell death

Stress signals sent by the endoplasmic reticulum could explain the mechanism of cell death in the tumor core and during ischemic episodes

]]>
http://www.idibell.cat/modul/news/ca/996/starvation-causes-atypical-cell-death2017-05-03
IDIBELL and ICO researchers take part in RCD Espanyol’s Heath Day ]]>http://www.idibell.cat/modul/news/ca/995/idibell-and-ico-researchers-take-part-in-rcd-espanyols-heath-day2017-04-28Chemoresistance in breast cancer is associated with the modulation of tumor cell populations ]]>http://www.idibell.cat/modul/news/ca/994/chemoresistance-in-breast-cancer-is-associated-with-the-modulation-of-tumor-cell-populations2017-04-28IDIBELL researchers look for new drugs against melanoma ]]>http://www.idibell.cat/modul/news/ca/992/idibell-researchers-look-for-new-drugs-against-melanoma2017-04-21Researchers describe a new pathophysiological process of megalencephalic leukoencephalopathy (MLC) in astrocytes ]]>http://www.idibell.cat/modul/news/ca/993/researchers-describe-a-new-pathophysiological-process-of-megalencephalic-leukoencephalopathy-mlc-in-astrocytes2017-04-24Bellvitge research receives 1 million euros in PERIS 2016-2020 funding ]]>http://www.idibell.cat/modul/news/ca/990/bellvitge-research-receives-1-million-euros-in-peris-2016-2020-funding2017-04-11First photoactive drug for pain treatments

Experts from the Institute of Neurosciences of the University of Barcelona, the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Advanced Chemistry of Catalonia (IQAC) from CSIC, are designing the first light-operated drug to treat pain

]]>
http://www.idibell.cat/modul/news/ca/991/first-photoactive-drug-for-pain-treatments2017-04-11
An epigenetic lesion could be responsible for acute T-cell leukemia ]]>http://www.idibell.cat/modul/news/ca/989/an-epigenetic-lesion-could-be-responsible-for-acute-t-cell-leukemia2017-03-30The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer ]]>http://www.idibell.cat/modul/news/ca/988/the-it-liver-european-consortium-unveils-new-tgf-beta-functions-in-liver-cancer2017-03-28The research in Neurofibromatosis receives again the support of the city of Manlleu ]]>http://www.idibell.cat/modul/news/ca/986/the-research-in-neurofibromatosis-receives-again-the-support-of-the-city-of-manlleu2017-03-22After the epigenome: the epitranscriptome ]]>http://www.idibell.cat/modul/news/ca/987/after-the-epigenome-the-epitranscriptome2017-03-22The second edition of IDIBELL PhD day highlights the potential of young researchers ]]>http://www.idibell.cat/modul/news/ca/984/the-second-edition-of-idibell-phd-day-highlights-the-potential-of-young-researchers2017-03-20ICS visits IDIBELL ]]>http://www.idibell.cat/modul/news/ca/985/ics-visits-idibell2017-03-20Cryopreserved orthoxenografts broaden the scope of single cell sequencing technologies ]]>http://www.idibell.cat/modul/news/ca/982/cryopreserved-orthoxenografts-broaden-the-scope-of-single-cell-sequencing-technologies2017-03-15First large-scale interactome map of the largest membrane receptors group in humans ]]>http://www.idibell.cat/modul/news/ca/983/first-large-scale-interactome-map-of-the-largest-membrane-receptors-group-in-humans2017-03-15IDIBELL joins #HeForShe on International Women's Day ]]>http://www.idibell.cat/modul/news/ca/981/idibell-joins-heforshe-on-international-womens-day2017-03-10Lifestyle choices condition colon and rectal cancer risk more than genetics

The first risk prediction model based on data from the Spanish population is issued

]]>
http://www.idibell.cat/modul/news/ca/980/lifestyle-choices-condition-colon-and-rectal-cancer-risk-more-than-genetics2017-03-06
Barcelona will hold the new edition of the Congress of the Spanish Society of Pharmacology ]]>http://www.idibell.cat/modul/news/ca/979/barcelona-will-hold-the-new-edition-of-the-congress-of-the-spanish-society-of-pharmacology2017-03-01Zumba fundraiser for Rett Syndrome ]]>http://www.idibell.cat/modul/news/ca/978/zumba-fundraiser-for-rett-syndrome2017-03-15La Regata Carla presenta una segunda edición dinámica y solidaria

El dinero recaudado se destinará a la investigación sobre el Síndrome de Rett

]]>
http://www.idibell.cat/modul/news/ca/977/la-regata-carla-presenta-una-segunda-edicion-dinamica-y-solidaria2017-02-24
IDIBELL and the Integral Health Consortium begin a research integration process ]]>http://www.idibell.cat/modul/news/ca/976/idibell-and-the-integral-health-consortium-begin-a-research-integration-process2017-02-22La AECC-Cataluña otorga dos becas a investigadores IDIBELL en su Noche Solidaria ]]>http://www.idibell.cat/modul/news/ca/975/la-aecc-cataluna-otorga-dos-becas-a-investigadores-idibell-en-su-noche-solidaria2017-02-21Adenoviruses and the immune system join forces against cancer ]]>http://www.idibell.cat/modul/news/ca/974/adenoviruses-and-the-immune-system-join-forces-against-cancer2017-02-16Women and science: past, present and future ]]>http://www.idibell.cat/modul/news/ca/973/women-and-science-past-present-and-future2017-02-17Conference on health technologies within the Mobile World Congress framework ]]>http://www.idibell.cat/modul/news/ca/972/conference-on-health-technologies-within-the-mobile-world-congress-framework2017-02-10A Nature study reinforces the contribution of S6K1 kinase in obesity and aging

EPRS phosphorylation mediates S6K1-dependent metabolic responses related to obesity and aging

]]>
http://www.idibell.cat/modul/news/ca/971/a-nature-study-reinforces-the-contribution-of-s6k1-kinase-in-obesity-and-aging2017-02-08
100.000 pebrots contra el càncer ]]>http://www.idibell.cat/modul/news/ca/970/100000-pebrots-contra-el-cancer2017-02-03Bastos Medical, committed to IDIBELL’s ovarian cancer research ]]>http://www.idibell.cat/modul/news/ca/969/bastos-medical-committed-to-idibells-ovarian-cancer-research2017-02-01European experts highlight the potential of xenografts in personalized oncology ]]>http://www.idibell.cat/modul/news/ca/968/european-experts-highlight-the-potential-of-xenografts-in-personalized-oncology2017-01-30A new strategy to improve genetic diagnosis for families with hereditary cancer ]]>http://www.idibell.cat/modul/news/ca/967/a-new-strategy-to-improve-genetic-diagnosis-for-families-with-hereditary-cancer2017-01-27El Hotel Barcelona Princess entrega 16.000€ a la investigación de las enfermedades raras ]]>http://www.idibell.cat/modul/news/ca/966/el-hotel-barcelona-princess-entrega-16000-a-la-investigacion-de-las-enfermedades-raras2017-01-26Inactivation of the B2M gene is recurrent in lung cancer and may condition the response to immunotherapy ]]>http://www.idibell.cat/modul/news/ca/965/inactivation-of-the-b2m-gene-is-recurrent-in-lung-cancer-and-may-condition-the-response-to-immunotherapy2017-01-16SB Hotels Tarragona Marathon wants to tear down the wall of childhood cancer

In its 7th edition, the sports test will collect voluntary donations for the investigation of children's sarcoma that is carried out in the IDIBELL

]]>
http://www.idibell.cat/modul/news/ca/964/sb-hotels-tarragona-marathon-wants-to-tear-down-the-wall-of-childhood-cancer2017-01-11
A bronchial GPS based on digital imaging for the early detection of lung cancer ]]>http://www.idibell.cat/modul/news/ca/963/a-bronchial-gps-based-on-digital-imaging-for-the-early-detection-of-lung-cancer2017-01-17Gabriel Capellá, director of IDIBELL ]]>http://www.idibell.cat/modul/news/ca/962/gabriel-capella-director-of-idibell2016-12-30Researchers describe the causes of resistance of tumor cells to therapy with mTOR inhibitors ]]>http://www.idibell.cat/modul/news/ca/961/researchers-describe-the-causes-of-resistance-of-tumor-cells-to-therapy-with-mtor-inhibitors2016-12-21Researchers identify new suppressor effects of the NOX4 protein in liver cancer ]]>http://www.idibell.cat/modul/news/ca/960/researchers-identify-new-suppressor-effects-of-the-nox4-protein-in-liver-cancer2016-12-19L’Hospitalet Christmas Concerts raise funds for IDIBELL

The City Council and the research center join forces to raise funds against intellectual disability

]]>
http://www.idibell.cat/modul/news/ca/959/lhospitalet-christmas-concerts-raise-funds-for-idibell2016-12-19
CaixaImpulse funds an IDIBELL project on hospital-acquired infections ]]>http://www.idibell.cat/modul/news/ca/958/caixaimpulse-funds-an-idibell-project-on-hospital-acquired-infections2016-12-13Success of the 1st Charity Night for Research on Cystic Fibrosis ]]>http://www.idibell.cat/modul/news/ca/957/success-of-the-1st-charity-night-for-research-on-cystic-fibrosis2016-12-07IDIBELL, a ''Company with Value'' ]]>http://www.idibell.cat/modul/news/ca/956/idibell-a-company-with-value2016-12-01The first analysis of Ewing's sarcoma methyloma opens doors to new treatments ]]>http://www.idibell.cat/modul/news/ca/955/the-first-analysis-of-ewings-sarcoma-methyloma-opens-doors-to-new-treatments2016-11-30The EPICUP test, amongst the “Best ideas” 2016 ]]>http://www.idibell.cat/modul/news/ca/954/the-epicup-test-amongst-the-best-ideas-20162016-11-30New antiretroviral drugs decrease chances of HIV sexual transmission

A triple regimen based on an integrase inhibitor decreases viral load in semen very quickly, reducing transmission risk

]]>
http://www.idibell.cat/modul/news/ca/953/new-antiretroviral-drugs-decrease-chances-of-hiv-sexual-transmission2016-11-17
How does the brain of people who do not like music work? ]]>http://www.idibell.cat/modul/news/ca/952/how-does-the-brain-of-people-who-do-not-like-music-work2016-11-1811.850 euros for the investigation of children's sarcoma in IDIBELL

The "Viladecans Against Cancer" Association delivers the funds raised during the second edition of its traditional Paella

]]>
http://www.idibell.cat/modul/news/ca/950/11850-euros-for-the-investigation-of-childrens-sarcoma-in-idibell2016-11-14
IDIBELL joins the ADVANCECAT project to promote advanced therapies in Catalonia ]]>http://www.idibell.cat/modul/news/ca/949/idibell-joins-the-advancecat-project-to-promote-advanced-therapies-in-catalonia2017-11-27Good practices in the management of European FEDER/FSE research grants ]]>http://www.idibell.cat/modul/news/ca/948/good-practices-in-the-management-of-european-federfse-research-grants2016-11-10IDIBELL’s innovation strategy in Medesalud 2016 ]]>http://www.idibell.cat/modul/news/ca/947/idibells-innovation-strategy-in-medesalud-20162016-11-093 IDIBELL diabetes and obesity research teams receive funding from La Marató de TV3 Foundation

The projects led by researchers Antonio Agudo, Genevieve Buckland and Sara Kozma are among the 34 projects selected to find new ways of prevention, diagnosis and treatment for the two most frequent metabolic diseases in Catalonia

]]>
http://www.idibell.cat/modul/news/ca/945/3-idibell-diabetes-and-obesity-research-teams-receive-funding-from-la-marato-de-tv3-foundation2016-11-04
Scientists discover a cause of multiple resistance to cancer chemotherapy ]]>http://www.idibell.cat/modul/news/ca/946/scientists-discover-a-cause-of-multiple-resistance-to-cancer-chemotherapy2016-11-04IDIBELL and the Llobregat Business Forum, together in the 1st Research charity night

The benefits of the Night will fund a project against cystic fibrosis

]]>
http://www.idibell.cat/modul/news/ca/944/idibell-and-the-llobregat-business-forum-together-in-the-1st-research-charity-night2016-11-16
Researcher Marta Díez-Ferrer is awarded for a study that improves 3D rendering of the tracheobronchial tree ]]>http://www.idibell.cat/modul/news/ca/943/researcher-marta-diez-ferrer-is-awarded-for-a-study-that-improves-3d-rendering-of-the-tracheobronchial-tree2016-11-02Cancer causing human papillomavirus lineage originate by sexual transmission from Neanderthals ]]>http://www.idibell.cat/modul/news/ca/942/cancer-causing-human-papillomavirus-lineage-originate-by-sexual-transmission-from-neanderthals2016-10-27Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont ]]>http://www.idibell.cat/modul/news/ca/941/manel-esteller-josep-baselga-and-joan-massague-receive-the-xxviii-catalonia-international-prize-from-president-puigdemont2016-10-26Grupo Témporing supports IDIBELL's research on ELA ]]>http://www.idibell.cat/modul/news/ca/939/grupo-temporing-supports-idibells-research-on-ela2016-10-19Identified a key protein in the generation of B lymphocytes ]]>http://www.idibell.cat/modul/news/ca/938/identified-a-key-protein-in-the-generation-of-b-lymphocytes2016-10-14The XII Marató del Mediterrani raises 500 euros for autoimmune diseases research ]]>http://www.idibell.cat/modul/news/ca/937/the-xii-marato-del-mediterrani-raises-500-euros-for-autoimmune-diseases-research2016-10-13Researchers identify a key molecule in psoriasis development ]]>http://www.idibell.cat/modul/news/ca/936/researchers-identify-a-key-molecule-in-psoriasis-development2016-10-04The XII Mediterranean Marathon will run to overcome autoimmune diseases ]]>http://www.idibell.cat/modul/news/ca/935/the-xii-mediterranean-marathon-will-run-to-overcome-autoimmune-diseases2016-10-10IDIBELL presents its technology portfolio in Biospain 2016

From today until next Friday, the business development & innovation area of IDIBELL will participate in the eighth edition of Biospain 2016, the most important biotech event in southern Europe

]]>
http://www.idibell.cat/modul/news/ca/934/idibell-presents-its-technology-portfolio-in-biospain-20162016-09-29
When learning is fun – scientists prove how the brain simulates external rewards to boost memory formation ]]>http://www.idibell.cat/modul/news/ca/933/when-learning-is-fun-scientists-prove-how-the-brain-simulates-external-rewards-to-boost-memory-formation2016-09-26